Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 364

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 364
---
The proportion
of a person’s lifespan experienced while in good health has remained relatively constant, meaning that it is likely that the additional
years gained as a result of longer lifespans are often spent in poor health. If people can live extra years while in good health, as compared
to living longer while in diminished physical and mental health, the benefits to the individual and society at large would be significant.
As illustrated in the chart below, a key to optimized aging is to maximize lifespan while simultaneously maximizing health span.

Based on the
current trends in global aging, it is expected that the demand for products and services designed to extend lifespan and improve health
span among the aging population will continue to grow. Furthermore, the market for longevity-related products and services is currently
fragmented. Particularly as it relates to low-and middle-income countries, it is difficult for healthcare consumers to find and purchase
the products, technologies and services to address their individual aging needs. In order to capitalize on the high demand for longevity-related
products and services and the fragmentation that currently exists within the market, we aim to become a consolidator and leading provider
of advanced therapeutic, health monitoring and digital health technologies designed to restore tissue form and function and increase health
span for the rapidly growing aging population. To achieve this
goal, we intend to build on our existing platform of diversified technologies by leveraging our seasoned executive team to continue developing
and acquiring advanced technologies, products and services that address the growing market of age-related diseases and conditions.

| 10 | Id. |

| 11 | Id. |

| 12 | Allied Marker Research Report (2022) Longevity and Anti-senescence                                                                                                                    
 Therapy Market by Therapy (Senolytic Drug Therapy, Gene Therapy, Immunotherapy), by Application (Cancer, Others), by End user (Hospital,                                              
 Medical Service Institution): Global Opportunity Analysis and Industry Forecast, 2020- 2030. https://www.alliedmarketresearch.com/longevity-and-anti-senescence-therapy-market-A14010 |

| 13 | World Health Organization, Ageing and Health, October                    
 2022 https://www.who.int/news-room/fact-sheets/ detail/ageing-and-health |

| 14 | Id. |

| 193 |

Our Competitive Strengths

We believe the successful pursuit of
our strategy will be driven by the following competitive strengths:

Focus on needs of aging
population

One of the most
formidable demographic challenges facing the world is